Capital Change Notice

Capital Change Notice


12786918_1


Section 1: Issuer information
Name of issuer Promisia Healthcare Limited (PHL)
NZX ticker code PHL
Class of financial product Ordinary shares
ISIN NZPRPE0001S5
Currency New Zealand Dollars
Section 2: Capital change details
Number issued/acquired/redeemed 1,087,683,333 shares being:
 92,683,333 fully paid ordinary
shares (Director Shares);
 300,000,000 fully paid ordinary
shares (Investment Shares);
and
 695,000,000 fully paid ordinary
shares (Capitalisation
Shares).
Nominal value (if any) Not applicable
Issue/acquisition/redemption price per security $0.001
Nature of the payment (for example, cash or other
consideration)
Consideration for the Director Shares
being the partial capitalisation of
amounts of directors fees owing by PHL
to directors of PHL.
Consideration for the Investment Shares
being cash.
Consideration for the Capitalisation
Shares being the capitalisation of
amounts owing by PHL to the Brankin
Family Interest Trust.
Amount paid up (if not in full) Not applicable
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of
Financial Products of the Class, excluding any Treasury Stock,
in existence)
6.44%
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or the
Option (for example, the exercise price and exercise date)
Not applicable
Reason for issue/acquisition/redemption and specific authority
for issue/acquisition/redemption/ (the reason for change must
be identified here)
For the Director Shares and
Capitalisation Shares, reducing
liabilities.
For the Investment Shares, increasing
working capital.
Authorised by board resolutions and
shareholder approval.
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury
Stock) and the total number of Financial Products of the Class
held as Treasury Stock after the issue/acquisition/redemption.
17,989,480,784

In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
Not applicable
Specific authority for the issue, acquisition, or redemption,
including a reference to the rule pursuant to which the issue,
acquisition, or redemption is made
NZX Listing Rule 4.2.1(a), passed by
shareholder resolution at a special
meeting of shareholders held on 24
March 2021.

Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
New ordinary shares that rank equally
with existing ordinary shares.
Date of issue/acquisition/redemption 25 March 2021
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement Stephen Underwood
Contact person for this announcement Stephen Underwood
Contact phone number +64 27 499 3387
Contact email address stephen@renouf.co.nz
Date of release through MAP

25 March 2021